Acuta Capital Partners, LLC Ocular Therapeutix, Inc Transaction History
Acuta Capital Partners, LLC
- $40.2 Million
- Q2 2025
A detailed history of Acuta Capital Partners, LLC transactions in Ocular Therapeutix, Inc stock. As of the latest transaction made, Acuta Capital Partners, LLC holds 1,014,940 shares of OCUL stock, worth $12.9 Million. This represents 23.41% of its overall portfolio holdings.
Number of Shares
1,014,940
Previous 1,219,724
16.79%
Holding current value
$12.9 Million
Previous $8.94 Million
5.35%
% of portfolio
23.41%
Previous 16.96%
Shares
8 transactions
Others Institutions Holding OCUL
# of Institutions
203Shares Held
137MCall Options Held
743KPut Options Held
321K-
Deep Track Capital, LP Greenwich, CT14.3MShares$182 Million4.71% of portfolio
-
Summer Road LLC West Palm Beach, FL13.9MShares$177 Million98.75% of portfolio
-
Vr Adviser, LLC New York, NY12.8MShares$162 Million23.46% of portfolio
-
Black Rock Inc. New York, NY11.5MShares$146 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA8.39MShares$107 Million0.0% of portfolio
About OCULAR THERAPEUTIX, INC
- Ticker OCUL
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 76,966,896
- Market Cap $978M
- Description
- Ocular Therapeutix, Inc., a biopharmaceutical company, focuses on the formulation, development, and commercialization of therapies for diseases and conditions of the eye using its bioresorbable hydrogel-based formulation technology. The company markets ReSure Sealant, an ophthalmic device to prevent wound leaks in corneal incisions following cat...